These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31051235)

  • 1. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.
    Leandro K; Bicker J; Alves G; Falcão A; Fortuna A
    Pharmacol Res; 2019 Jun; 144():357-376. PubMed ID: 31051235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
    Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
    Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
    Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
    Xiong J; Mao DA; Liu LQ
    Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
    Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
    Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery.
    Mohi-Ud-Din R; Mir RH; Mir PA; Banday N; Shah AJ; Sawhney G; Bhat MM; Batiha GE; Pottoo FH
    Curr Drug Metab; 2022; 23(9):735-756. PubMed ID: 35980054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
    Löscher W; Potschka H
    NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.
    Grewal GK; Kukal S; Kanojia N; Saso L; Kukreti S; Kukreti R
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the possible interaction between anti-epilepsy drugs and multidrug efflux pumps; in vitro observations.
    Rivers F; O'Brien TJ; Callaghan R
    Eur J Pharmacol; 2008 Nov; 598(1-3):1-8. PubMed ID: 18835265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
    Potschka H
    Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Neuroinflammation on ABC Transporters: Possible Contribution to Refractory Epilepsy.
    Deng X; Xie Y; Chen Y
    CNS Neurol Disord Drug Targets; 2018; 17(10):728-735. PubMed ID: 30152292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC Transporters and Drug Resistance in Patients with Epilepsy.
    Feldmann M; Koepp M
    Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
    Soranzo N; Kelly L; Martinian L; Burley MW; Thom M; Sali A; Kroetz DL; Goldstein DB; Sisodiya SM
    Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.
    Potschka H
    Adv Drug Deliv Rev; 2012 Jul; 64(10):943-52. PubMed ID: 22210135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
    Cerveny L; Pavek P; Malakova J; Staud F; Fendrich Z
    Epilepsia; 2006 Mar; 47(3):461-8. PubMed ID: 16529607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance in epilepsy: the role of the blood-brain barrier.
    Abbott NJ; Khan EU; Rollinson CM; Reichel A; Janigro D; Dombrowski SM; Dobbie MS; Begley DJ
    Novartis Found Symp; 2002; 243():38-47; discussion 47-53, 180-5. PubMed ID: 11990780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
    Orlandi A; Paolino MC; Striano P; Parisi P
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives.
    Langeh U; Chawla P; Gupta GD; Singh S
    CNS Neurol Disord Drug Targets; 2020; 19(10):741-749. PubMed ID: 32814543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.